Solid Biosciences Inc. Initial Public Offering
Davis Polk advised the joint book-running managers in connection with the $133.7 million initial public offering of common stock of Solid Biosciences Inc. The common stock is listed on the…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
ConforMIS, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering of 13,333,333 shares of common stock of ConforMis,…
Ablynx NV $230 Million U.S. Initial Public Offering of ADSs and Listing on the NASDAQ
Davis Polk advised the representatives of the several underwriters in connection with Ablynx NV’s offering of $230 million of its ordinary shares in the form of American Depositary…
Advanced Accelerator Applications $3.9 billion acquisition by Novartis
Davis Polk is advising Advanced Accelerator Applications S.A. on its $3.9 billion acquisition by Novartis. Entry into the definitive agreement has been approved by the board of…
Davis Polk Advises GeoPark Limited on Its $425 Million Notes Offering and Cash Tender Offer
Davis Polk advised GeoPark Limited in connection with the offering of $425 million aggregate principal amount of its 6.500% senior secured notes due 2024. The notes were sold in an…
Davis Polk Advises Banco de Bogotá S.A. on Its $600 Million Global Senior Notes Offering
Davis Polk advised Banco de Bogotá S.A. in connection with its global offering of $600 million aggregate principal amount of its 4.375% senior notes due 2027, pursuant to Rule 144A and…
XPO Logistics, Inc. $665.5 Million Common Stock Offering and Forward Sale Agreements
Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering of 11,000,000 shares of common stock of XPO Logistics, Inc. and advised the…
Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…
Callon Petroleum Company $200 Million Senior Notes Reopening
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of $200 million aggregate principal amount of Callon Petroleum Company’s…
Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 7,000,000 shares of Class A common stock of Evolent Health, Inc. by certain of…